Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort
- PMID: 33423327
- DOI: 10.1111/fcp.12640
Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort
Comment on
-
Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort.Fundam Clin Pharmacol. 2021 Feb;35(1):186-191. doi: 10.1111/fcp.12580. Epub 2020 Jul 7. Fundam Clin Pharmacol. 2021. PMID: 32564375
References
REFERENCES
-
- Weiss J., Torrents R., Verhamme B. et al. Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort. Fundam. Clin. Pharmacol. (2020) https://doi.org/10.1111/fcp.12580
-
- Dujourdy L., Besacier F. A study of cannabis potency in France over a 25 years period (1992-2016). Forensic Sci. Int. (2017) 272 72-80.
-
- Schreck B., Wagneur N., Caillet P. et al. Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network. Drug Alcohol Depend. (2018) 182 27-32.
-
- Claudet I., Mouvier S., Labadie M. et al. Unintentional Cannabis Intoxication in toddlers. Pediatrics (2017) 140 e20170017.
-
- Nasser Y., Woo M., Andrews C.N. Cannabis in gastroenterology: watch your head! A review of use in inflammatory bowel disease, functional gut disorders, and gut-related adverse effects. Curr. Treat. Options Gastroenterol. (2020) 21 1-12.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources